812667-44-0

Basic information

• Product Name: 4-BroMo-2-MethoxybenzaMide
• Synonyms: 4-BroMo-2-MethoxybenzaMide
• CAS NO: 812667-44-0
• Molecular Formula: C₈H₈BrNO₂
• Molecular Weight: 230.05862
• Mol File: 812667-44-0.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 305.9°C at 760 mmHg
• Flash Point: 138.8°C
• Appearance: /
• Density: 1.551g/cm³
• Vapor Pressure: 0.000798mmHg at 25°C
• Refractive Index: 1.582
• CAS DataBase Reference: 4-BroMo-2-MethoxybenzaMide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BroMo-2-MethoxybenzaMide(812667-44-0)
• EPA Substance Registry System: 4-BroMo-2-MethoxybenzaMide(812667-44-0)

Safety Data

• Hazardous Substances Data: 812667-44-0(Hazardous Substances Data)

Usage

InChI:InChI=1/C8H8BrNO2/c1-12-7-4-5(9)2-3-6(7)8(10)11/h2-4H,1H3,(H2,10,11)

Upstream product

• 5213-16-1 4-bromo-2-methoxybenzoyl chloride 
• 139102-34-4 methyl 4-bromo-2-methoxybenzoate 
• 330793-38-9 4-bromo-2-methoxybenzonitrile 
• 72135-36-5 4-bromo-2-methoxybenzoic acid 

Downstream Products

• 330793-38-9 4-bromo-2-methoxybenzonitrile 
• 1246765-30-9 2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide 
• 5428-40-0 4-bromo-2-hydroxybenzamide 
• 812667-45-1 4-bromo-2-methoxybenzamidine hydrochloride 
• 1018326-11-8 4-(4-(2-(4-chloro-5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)acetyl)piperidin-1-yl)-2-methoxybenzonitrile 

Relevant articles and documents

Explicit treatment of active-site waters enhances quantum mechanical/implicit solvent scoring: Inhibition of CDK2 by new pyrazolo[1,5-a]pyrimidines

We present comprehensive testing of solvent representation in quantum mechanics (QM)-based scoring of protein-ligand affinities. To this aim, we prepared 21 new inhibitors of cyclin-dependent kinase 2 (CDK2) with the pyrazolo[1,5-a]pyrimidine core, whose

4, 5-DIHYDRO-LH-PYRAZOLE COMPOUNDS AND THEIR PHARMACEUTICAL USES

Mineralocorticoid receptor antagonists (MRa), pharmaceutical compositions containing such inhibitors and the use of such inhibitors to treat, for example, diabetic nephropathy and hypertension in mammals, including humans.

IMIDAZOTRIAZINONE DERIVATIVES AS PDE 7 (PHOSPHODIESTERASE 7) INHIBITORS

The present invention provides the compounds inhibiting PDE 7 selectively, and therefore, enhances cellular cAMP level. Consequently, the compound is useful for treating various kinds of disease such as allergic disease, inflammatory disease or immunologi